"Let food be your medicine, and let medicine be your food" Hippocrates (^^ - 500BC)
 
 
 

Nutri Pharma ASA

Kronprinsesse Marthas
Plass 1
P.O Box 1477, Vika
N-0116 Oslo
Norway

Telephone +47 23 01 09 60
Telefax +47 23 01 09 70
Send e-mail
 
 
 

Mandatory Notification of Trade

09.12.2008 - Board member Lars H. Høie has today purchased 503.485 NUT shares at NOK 1,26 per share...
 

Mandatory Notification of Trade

08.12.2008 - Development Director - Mike Clenshaw New has today purchased 500.000 NUT shares at NOK 1,25 per share from Lars Høie...
 

Nutri5® Distribution Product Supply and Marketing Support Agreement

05.12.2008 - Nutri Pharma ASA has today signed a Distribution, Product Supply and Marketing Support Agreement with Nikken UK Ltd. This agreement will give Nikken the exclusive European distribution rights for Nutri5®...
 

Third quarter 2008

20.11.2008 - Nutri Pharma today reports consolidated revenues of MNOK 23.9 and a consolidated EBIT of MNOK 0.2 for Q3 2008.....
 

Meldepliktig handel

27.02.2008 - Mininaste AS, kontrollert av Dr. med. Egil Bodd, har i dag kjøpt 2 millioneraksjer i Nutri Pharma ASA av Lars H. Høie til kurs NOK 2,30 pr. aksje...
 

Nutri5 lanseres 8. februar på helsemessen Norges varemesse

10.01.2008 - Nutri5® - et nytt produkt for kvinner - reduserer plager relatert til menopause og PMS - forbedrer kvinners helse og livskvalitet
 

Fourth Quarter 2007

27.02.2008 - (Oslo, 27 February 2008) Nutri Pharma (OSE: NUT)today reports revenues of NOK 17.4 million and an EBITDA of NOK - 2.9 million for the fourth quarter of 2007...
 

First order placed for `Nutrilett` in the Czech Republic

Nutri Pharma ASA has today received the first order from Delpharmea. This order is meant for a pre-launch of `Nutrilett`, marketed as Nutriline in the 350-400 largest pharmacies.
 

Notice of Annual General Meeting

The annual general meeting of Nutri Pharma ASA will be held Tuesday 29 April 2008, 10:00 a.m.
 

First half year report 2008

MIG reports revenues of MNOK 23.4 which is 32 % higher than Q1 2008 and an increase of 34 % compared with Q2 2007.
 

Approved annual accounts 2007

On the 28 of March 2008, the Board of Directors of Nutri Pharma ASA approved the annual accounts for 2007.
 

Distribution and supply agreement for `Nutrilett`

Nutri Pharma ASA has today signed a distribution and supply agreement with Delpharmea Nutraceuticals AS in the Czech Republic.
 

First Quarter 2008

Nutri Pharma today reports consolidated revenues of MNOK 19.9 million (an increase of 47 % compared with Q1 2007) and a consolidated loss of MNOK 3.2 million for the first quarter of 2008.
 
2006 Nutri Pharma ASA Telephone +47 23 01 09 60 Telefax +47 23 01 09 70   Contact Page